Erasca, Inc. (ERAS) stock
ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
$15.66−0.12 (-0.76%)
Close on Nov 13, 2026Market cap $5.48BP/E –Yield 0.00%
Erasca enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Erasca's enterprise value was $4.87B on Nov 11, 2026, against $536.97M a year earlier. Over the last 5 years it ranged from -$45.30M to $5.29B, with a median of $275.21M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.87B | +602.2% |
| 2025 | Dec 31, 2025 | $693.01M | +77.4% |
| 2024 | Dec 31, 2024 | $390.65M | +1531.4% |
| 2023 | Dec 29, 2023 | $23.95M | -85.6% |
| 2022 | Dec 30, 2022 | $165.72M | -87.8% |
| 2021 | Dec 31, 2021 | $1.36B | – |
See a number that looks wrong?